Molecular Analysis of the HIV-1 Resistance Development: Enzymatic Activities, Crystal Structures, and Thermodynamics of Nelfinavir-resistant HIV Protease Mutants-Reference-Cited by-同舟云学术

Molecular Analysis of the HIV-1 Resistance Development: Enzymatic Activities, Crystal Structures, and Thermodynamics of Nelfinavir-resistant HIV Protease Mutants

Published:2007-12 Issue:4 Volume:374 Page:1005-1016
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Kožíšek Milan,Bray Jenelle,Řezáčová Pavlína,Šašková Klára,Brynda Jiří,Pokorná Jana,Mammano Fabrizio,Rulíšek Lubomír,Konvalinka Jan

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference48 articles.

1. Structural biology of HIV;Turner;J. Mol. Biol.,1999

2. Active human immunodeficiency virus protease is required for viral infectivity;Kohl;Proc. Natl Acad. Sci. USA,1988

3. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors;Condra;Nature,1995

4. Design of HIV-1 protease inhibitors active on multidrug-resistant virus;Surleraux;J. Med. Chem.,2005

5. Nelfinavir: an update on its use in HIV infection;Bardsley-Elliot;Drugs,2000

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating how HIV-1 antiretrovirals differentially behave as substrates and inhibitors of P-glycoprotein via molecular dynamics simulations;Computational and Structural Biotechnology Journal;2024-12

2. Interaction Analysis by Fragment Molecular Orbital Method for Drug Discovery Research;Chemical and Pharmaceutical Bulletin;2024-09-01

3. Exploration of imatinib and nilotinib-derived templates as the P2-Ligand for HIV-1 protease inhibitors: Design, synthesis, protein X-ray structural studies, and biological evaluation;European Journal of Medicinal Chemistry;2023-07

4. Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease;ACS Infectious Diseases;2023-06-30

5. Systematic analyses of the resistance potential of drugs targeting SARS-CoV-2 main protease;2023-03-02